BromAc

N/A

Report date: 2024/11/27 20:00:40
NME

Base Information

Drug NameBromAc
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals inhibitorsMucin-1 inhibitors
TargetsFree radicalsMucin-1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultPneumonia, Ventilator-Associated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Bromelain (Mucpharm)Acetylcysteine
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMucpharm Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMucpharm Pty Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultPneumonia, Ventilator-Associated

Other Information

ATC CodeN/A
Related LinksN/A